All In MedTech

Device Trial Radar · NCT04248283

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

167

Planned (sponsor's estimate)

Start

Jan 26, 2021

Primary completion

May 31, 2027

Study completion May 31, 2032

Sponsor

Lead sponsor
UromedicaNot on our public-company list
Sponsor type
Industry
First posted
Jan 30, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

Conditions

  • Urinary Incontinence
  • Urinary Incontinence,Stress

Interventions

  • Adjustable Continence Therapy for Women (ACT)Device

    Two ACT devices are implanted in each patient. The devices are intended for implantation in the paraurethral space, with the balloons located on each side of the urethra near the bladder neck. The ports are placed subcutaneously in the labia majora. The balloons are filled after implantation with an isotonic solution via needle injection into the port. The ACT implant can be placed using local, spinal or general anesthesia with the surgical instruments (provided separately).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Provocative pad weightTime frame: 12 months

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Colorado

    Denver, Colorado · Recruiting

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.